Precigen (PGEN) Long-Term Debt Repayments (2013 - 2023)

Precigen's (PGEN) quarterly Long-Term Debt Repayments came in at $13.9 million in Q2 2023, up 12193.81% year-on-year from N/an in Q2 2022, and down 52.63% on a QoQ basis from $29.3 million in Q1 2023.

Precigen (PGEN) Long-Term Debt Repayments (2013 - 2023) Analysis & Trends

Precigen (PGEN) has 11 years of Long-Term Debt Repayments data on file, last reported at $13.9 million in Q2 2023.

  • On a quarterly basis, Long-Term Debt Repayments rose 12193.81% year-over-year to $13.9 million in Q2 2023; TTM through Mar 2024 was $13.9 million, a 92.47% decrease from a year earlier, with the FY2023 full-year figure at $43.2 million, down 72.17% from the prior year.
  • Long-Term Debt Repayments for Q2 2023 stood at $13.9 million, down from $29.3 million in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for PGEN reached as high as $115.7 million in Q3 2022 and fell as low as $113000.0 in Q2 2022.
  • Historically, Long-Term Debt Repayments has averaged $11.1 million across 5 years, with a median of $137500.0 in 2019.
  • Across the five-year window, Long-Term Debt Repayments retreated 29.9% in 2019 and surged 98817.95% in 2022, its largest moves.
  • Year by year, Long-Term Debt Repayments stood at $154000.0 in 2019, then dropped by 22.08% to $120000.0 in 2020, then decreased by 4.17% to $115000.0 in 2021, then soared by 34058.26% to $39.3 million in 2022, then slumped by 64.64% to $13.9 million in 2023.
  • Per Business Quant data, the three most recent Long-Term Debt Repayments figures were $13.9 million in Q2 2023, $29.3 million in Q1 2023, and $39.3 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.64 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 13.89 Mn
Jun 30, 2023 13.89 Mn
Mar 31, 2023 29.33 Mn
Mar 31, 2023 29.33 Mn
Dec 31, 2022 39.28 Mn
Dec 31, 2022 39.28 Mn
Sep 30, 2022 115.73 Mn
Sep 30, 2022 115.73 Mn
Jun 30, 2022 113,000.00
Jun 30, 2022 113,000.00
Mar 31, 2022 164,000.00
Mar 31, 2022 164,000.00
Dec 31, 2021 115,000.00
Dec 31, 2021 115,000.00
Sep 30, 2021 117,000.00
Sep 30, 2021 117,000.00
Jun 30, 2021 118,000.00
Jun 30, 2021 118,000.00
Mar 31, 2021 116,000.00
Mar 31, 2021 116,000.00